Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells

Matthew J Loza1, Susan Foster, Stephen P Peters

  • 1Department of Internal Medicine, Center for Human Genomics, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157, USA.

Blood
|November 10, 2005
PubMed

Insights

Beta-agonists directly activate beta2-adrenergic receptors (beta2AR) on T cells, modulating immune responses. This study reveals complex roles for G-protein-coupled receptors (GPCRs) and protein kinase A (PKA) in T-cell subtype function.

Area of Science:

  • Immunology
  • Cellular Signaling
  • Pharmacology

Background:

  • The beta2-adrenergic receptor (beta2AR) is a well-studied G-protein-coupled receptor (GPCR).
  • The impact of beta-agonists on T-cell subtype function is not fully understood.
  • Previous studies suggested a lack of beta2AR expression on type 2 T cells.

Purpose of the Study:

  • To investigate the direct effects of beta-agonists on T-cell subtype function.
  • To explore the role of beta2AR activation in human peripheral blood lymphocytes (PBLs).
  • To elucidate the signaling pathways involved in beta-agonist-mediated T-cell modulation.

Main Methods:

  • Analysis of type 2 interleukin-13+ (IL-13+) T cells (CD4+ or CD8+) from human PBLs.
  • Measurement of protein kinase A (PKA) activity.
  • Assessment of CD25 expression and cytokine production (IL-13, IFN-gamma, IL-2) following stimulation.
  • Evaluation of p38 mitogen-activated protein kinase (MAPK) phosphorylation and other signaling pathways (p42/p44, NF-kappaB).

Main Results:

  • Type 2 T cells express functional beta2AR, responding to beta-agonists.
  • Beta-agonist stimulation induced PKA activity and inhibited CD3-stimulated CD25 expression, IL-13, IFN-gamma, and IL-2 production.
  • Prostaglandin E2 (PGE2) was more potent than beta-agonist in PKA activation and cytokine inhibition.
  • Differential regulation of signaling pathways explained the selective inhibition of IFN-gamma and IL-13.
  • Low concentrations of beta-agonist and PGE2 enhanced IL-13 production, but not IFN-gamma or IL-2.

Conclusions:

  • Beta2AR activation has direct effects on T-cell subtypes.
  • GPCRs and PKA play complex roles in modulating T-cell functions.
  • Findings challenge previous assumptions about beta2AR expression and function in T cells.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...